S U M M A R Y 1. Plasma aspartate transaminase and alkaline phosphatase activities were measured weekly for approximately 30 weeks in a group of healthy males and females.
biotics. In such studies it is not unusual to find occasional elevated values of one of these enzymes, and it would be useful when assessing results of such tests to know how much importance to place on these variations. As little is known about the normal fluctuations of these plasma enzymes over a long period it is possible that an occasional elevated value might be part of the normal variation.
Investigations were done to determine normal variation over a prolonged period for a number of blood constituents (Glassy & Blumenfeld, 1968; Mefferd & Pokorny, 1967; Cotlove, Harris & Williams, 1970; Harris, Kanofsky, Shakarji & Cotlove, 1970; Williams, Young, Stein & Cotlove, 1970; Young, Harris & Cotlove, 1971) , which have included aspartate transaminase (AST) and alkaline phosphatase (ALP). These studies have yielded conflicting results concerning the variability of these enzyme activities.
The aim of the present study was to provide further information on the magnitude of any variations in the activities of these enzymes in plasma to decide on the significance of isolated values falling outside accepted normal ranges.
M A T E R I A L S A N D M E T H O D S
This survey was carried out on a group of healthy volunteers, chiefly laboratory workers in the Royal Free Hospital. There were seventeen females, whose ages ranged from 21 to 54 years, and twenty males whose ages ranged from 20 to 62 years. The initial selection excluded those who were regularly taking oral contraceptive agents or soporifics.
Venous blood samples were obtained without stasis from the antecubital veins of the volunteers at weekly intervals, 1-2 h after breakfast. Samples were collected in plastic tubes with lithium-heparin as the anticoagulant. Separation of the samples was done within 1 h of collection, and the supernatant plasma divided into two portions. One was stored at 4°C for subsequent measurement of ALP, and the other at -20°C for measurement of AST. Estimation of the alkaline phosphatase activities was performed within 24 h of sample collection, and of the aspartate transaminase activities between 2 and 10 days after collection. Storage of AST for this period is not associated with a fall in activity (Hanok & Kuo, 1968) .
The investigation was continued for a total period of 8 months, until most subjects had contributed between twenty-five and thirty samples to the survey.
Both assays were performed under standard working conditions in a busy routine laboratory using the methods normally employed, at the same time as the assays on patients.
Measurement of alkaline phosphatase was carried out on a Technicon AutoAnalyzer. The automated procedure (Bell & Collier, 1964 ) is modified from Kind & King (1954) .
The method used for estimation of aspartate transaminase is based on that of Karmen (1955) . The final cuvette reagent amounts used were as follows: 0.75 ml of 0.1 M-phosphate buffer, pH 7.4, containing 0.04 M-L-aspartate; 0-0125 ml of 0.012 M-NADH; 0.0125 ml of a solution containing 0.25 mg of malate dehydrogenaselml and 0-25 mg of lactate dehydrogenaselml; 0.025 ml of 0.25 M-a-oxoglutarate; and 0.125 ml of plasma. Reagents for this assay were used as a Boehringer kit (GOT-UV method, Cat. No. TGAE 15971) . This procedure gives lower values for the serum transaminases than those generally accepted, by a ratio of 5 : 4 (Baron, Levin & Wilkinson, 1971 ).
An LKB reaction-rate analyser was used to monitor the optical density changes. The operating temperature of the instrument is 35"C, and despite the known problems of tempera-ture correction, a factor of 0.53 (King, 1965) was used to express the results at 25"C, normal ranges at this temperature being more familiar to the hospital staff.
The control serum used in this investigation was an unassayed freeze-dried Burroughs Wellcome serum preparation. Samples were reconstituted immediately before measurement of enzyme activities. The control serum was obtained from a single pool of freeze-dried material and sufficient was available for the duration of the study. The control material was stored at -20°C.
Samples were analysed in the same order for each assay throughout the study, the samples from female subjects being analysed after those from male subjects. With each batch of specimens two control samples were analysed, one after the samples from the male subjects, and the other after the samples from the female subjects. Tables 1 and 2 summarize the results obtained for the individual subjects and for the control serum. For each subject the results for both enzymes were plotted on arithmetic and logarithmic probability paper to determine the distribution of the enzyme activities within individuals. Although the plots obtained for subjects whose values occupied the middle and lower parts of the clinical normal range (alkaline phosphatase 3-13 K.A. units/lOO ml, and aspartate transaminase 4-12 i.u./l) appeared to fit a Gaussian distribution, the plots for subjects with higher values were positively skewed. A transformation of the original observations to common logarithms showed that a log,, Gaussian distribution best described the situation within all subjects. Values were therefore expressed as the log, , in all subsequent calculations.
RESULTS
A second consequence of the logarithmic transformation on estimations of this kind is to stabilize the variance. This is necessary where the magnitude of the variation of a particular estimation is proportional to the mean value, i.e. where a high standard deviation (SD) is associated with a high enzyme activity.
In the original estimates this was a feature of the data, particularly in the control serum used for the AST assays, where the mean activity was approximately seven times that of the estimates on subjects. If it is assumed that the analytical variation is proportional to the mean activity, then taking the log,, of all observations makes the observed variation directly comparable whether or not the mean activities are similar.
For each enzyme a mean and standard deviation were calculated for the sample as a whole. The mean for alkaline phosphatase including all results from all subjects was 7.0 K.A. units/ 100 ml with a normal range, i.e. antilog (mean& 1-96 SD) of 3.9-12.7 K.A. units/lOO ml. Male subjects had a mean of 8.5 K.A. units/lOO ml and a normal range of 4-7-15.3 K.A. units/100 ml. Female subjects had a mean of 5.6 K.A. units/100 ml and a normal range of 3.1-10-1 K.A. units/lOO ml. The difference between the means for male and female subjects is highly significant (t-test, P<O.OOl).
The mean for aspartate transaminase including all results from all subjects was 7.0 i.u./l with a normal range of 4.4-11-2 i.u./l. Male subjects had a mean of 7.8 i.u./l and a normal range of 4-6-13.0 i.u./l. Female subjects had a mean of 6.2 i.u./l and a normal range of 4.1-9.3 i.u./l. Again the sex difference is highly significant (P<O.OOl).
The differences in the mean activities of the two enzymes between individuals should be noted (Tables 1 and 2 ) as should the variability of the enzyme activities within an individual. The latter can also be seen to vary from person to person. To detect and explain the presence of peaks of enzyme activity the results were examined in several ways. In this study it is important to consider amounts of ALP or AST activities that are in some sense abnormal. The precise sense in which these results are abnormal is a matter of choosing a definition which will tend to minimize the number of otherwise normal results which are classified as being abnormal, together with a definition that will correctly classify abnormal results as being in the abnormal group. The conventional approach was adopted of taking the normal range as being the 95% points of a distribution of enzyme values estimated from a particular sample of normal people. Such a procedure tends to provide an upper limit of normal which is exceeded in 2.5% of assays on healthy individuals. There are several ways in which this distribution of normal values can be estimated and in the analysis four approaches were used so that a comparison of abnormal values by the four criteria could be made and their implications discussed.
(a) The activities of the two enzymes for all subjects were examined in relation to the clinically accepted normal ranges. The upper limit of normal used at the Royal Free Hospital laboratory for ALP is 13 K.A. units/100 ml and for AST it is 12 i.u.11. Of the 971 estimations of ALP from this sample of normal people forty-one were higher than 13 K.A. units/lOO ml, and of the 970 AST estimations thirty-two were higher than 12 i.u./l. On the hypothesis that all individuals in the survey were at all times healthy it appears that these upper limits of normal are a little too low as rather more than 4% of ALP and 3% of AST values were above their upper limits. Of the assays that were above these limits certain features became apparent. First, the results for the female subjects were rarely above these limits, which emphasizes the sex difference in activities described above; indeed, only three of the seventy-three high values recorded were among female subjects. Secondly, those results that were above the upper limit of normal tended to be grouped together either in the same individual, indicating either higher activities or wider variability in particular subjects, or in the same week of analysis, indicating the same phenomenon in particular weeks (see Figs. 1 and 2 ). Thus these abnormal results seemed to occur in a systematic rather than a random fashion. The magnitude of these values was never very large. Thus twenty-eight ALP values lay between 13 and 15 K.A. units/100 ml and the highest value found was 19 K.A. units/l00 ml. Of the forty-two AST values above 12 i.u./l, thirty-seven lay between 12 and 16 i.u./l and the highest value found was 23 i.u./l.
Weekly
The observed variation in enzyme activities may be considered with respect to four components. First, the variation that exists between different people (between-person variation). This includes factors such as age, sex, diet, etc. Secondly, the variation that occurs in a single individual with time (within-person variation) on an hour-to-hour, day-to-day, week-toweek basis, etc. These components of variation may be termed 'biological' as opposed to variations arising from the actual analysis. Analytical variation can be sub-divided into a within-batch component (the variation of the results of assays on the same sample in a single batch) and a between-batch component (the variation of assays on the same sample analysed in different batches), which includes that variation attributable to within-batch error.
(b) The consecutive weekly assays for each individual provide an estimate of the distribution of each enzyme within that individual with time. This distribution includes within-person variation and within-and between-batch error but not between-person variation. These distributions are summarized in Tables 1 and 2 and it can be seen that the mean values for each individual vary between people as do the standard deviations indicating a considerable variation in within-person variation. It can also be seen that for both enzymes the mean values of the females are, on the whole, lower than those for males.
(c) Because of the large sex difference it would be more appropriate to examine the distribution of the assays for each sex separately. An estimate is thus obtained of the distribution of repeated measurements for the same person confounded with between-person (but withinsex) variation and laboratory error. Those results which are higher than the 97.5% point on this distribution represent a new set of abnormal results. They are shown in Figs. 1 and 2 as the results which exceed the sample normal range. These observations appear predominantly in groups either within the same individual or in the same week of analysis or both. The former is a manifestation of between-person variability and the latter of between-batch variability.
(d) To investigate this situation in more detail the data were examined for abnormality defined in a fourth sense. For each enzyme in this study there is an overall mean value for all the assays equal top.
The mean value for each individual over the duration of the study will, in general, be different from this overall mean. Similarly, the mean value for each week for all the subjects assayed in that week will also be different from the overall mean. If a, is the difference of the mean value for the ith subject from the overall mean and Pj is the difference of the mean value for thejth week from the overall mean, then the result of the assay on the ith subject on the j t h week can be compared with the result of computing: yij = p+ai+pj Hence a variable, E , may be defined for each assay which is equal to the actual result minus this yij derived from the overall means. If the distribution of the E values are examined a different normal range arises. In (c) above, the normal range examined included the variability in enzyme activities due to between-person variation and between-week variation. If a normal range based on the distribution of the E values is used these sources of variation are excluded because only deviations from within-person means and within-week means are measured. Hence those factors that appeared in our examination of more conventional normal ranges to be the source of variation which gave rise to apparently abnormal results, are omitted. Whether this source of variation could explain the existence of results above the conventional range in healthy people can be tested by comparing the latter observations with those higher than the 97.5% point on the distribution of E .
The distribution of the E term in this sample is shown in Table 3 . It can be seen that the standard deviation of this term for each enzyme is very different between the sexes.
The standard deviation of E among the subjects reflects within-person variation, and withinbatch analytical error, while in the control sera the SD of E should be an estimate of withinbatch variation only. The within-batch variation can also be estimated from those batches in which more than one control serum was analysed, and this yielded an SD of 0.0308 for the ALP, and 0.0306 for the AST assays. Neither of these values are significantly different from the SD of E for the control sera. The difference between the SD of E for the control samples and the subjects reflects the magnitude of the within-person variation, combined with any errors related to specimen collection and preservation. The variation in ALP for the male subjects and in AST for the female subjects is so similar to the within-batch variation that the contribution of a within-person variation is very small. However, for the ALP results for female subjects and the AST results for male subjects the combined biological and collection variation appears to be larger than the within-batch variation. The chance that these standard deviations are merely estimates of within-batch variations is very small (F-test : ALP, P<0*005; AST, P<O*Ol). It is not possible to estimate the contribution of errors related to specimen collection and storage to the value of E for the subjects, but it seems likely that effects due to storage of the enzymes are minimal (Hanok & Kuo, 1968) . Errors related to the collection of the samples are not well documented, but all samples were taken under the same conditions by one person (G.E.L.) throughout the duration of the study, and any errors relating to this would apply to all specimens obtained. The values obtained for the control sera include, in addition to within-batch variation, errors from two other sources : the initial quantity of freeze-dried serum dispensed in the container, and the volume of water used to reconstitute the serum.
These values emphasize the large part that laboratory error plays in the observed variation of these enzymes. If the top 2.5% in the best-fitting Gaussian distributions of E for the two enzymes separately by sex is taken, it is found that for the most part those observations whose value of E exceeds this limit (indicated by / on the Figures) are not the observations that were outside the clinical normal range, nor are they the observations that were outside the normal range derived from our data. Hence, taking into account differences between people and between weeks, a virtually new set of 'abnormal' results is obtained (Table 4 ). An indication of the difference between abnormal results indicated by the three criteria (a, c and d above) is shown in this Table, which shows those observations that were beyond the range defined above, further subdivided according to whether they were also larger than the upper limit of the clinical normal range and/or the range derived from our data.
The random nature of the positions of these abnormal results in Figs. 1 and 2 compared with more systematic distributions of results classified as abnormal by definitions not taking into account within-person or between-batch variation indicates the importance these sources of variation have to the observed distribution of enzyme activities. Of those results that were above the clinical normal range only a small fraction are also in the high tails of the distribution of E which suggests that most results which exceed this normal limit do so either because the individual concerned has a predominantly high enzyme activity or because the analysis of the batch in which the sample was submitted gives predominantly high results. A detailed analysis of the distribution of E showed that these distributions for each sex and for each enzyme were very close to Gaussian and that there were no outliers. 
DISCUSSION
The object of this study was to find out whether isolated estimations on a healthy individual fall outside clinically accepted normal ranges. The factors that influence the results of an assay are documented above. For the full explanation of spikes of activity of the two enzymes studied, the contributions of these factors to the normal range must be known.
The results obtained in this study gave limited information about the magnitude of the laboratory error because there was rarely more than one estimation on the same sample, and these were all in the control sera. Consequently, information about the magnitude of other sources of variation is limited because any variation observed might be entirely due to laboratory error, or, to within-person variation, or, more probably, a combination of influences. It was this consideration which prompted an analysis of the results with respect to the distribution of the term E which excluded the variation of the predominant enzyme activities of particular individuals, and the variation of enzyme activities on particular weeks. The term includes several other components of variation, particularly the within-person variation and the within-batch variability.
The initial analysis of the results indicated that the peaks of activity as defined under headings (a) and (c) above were not random events but occurred in groups associated with a particular individual or a particular week. When these effects were allowed for, and a new set of criteria calculated [(d) above], the resulting 'abnormal' values appeared more random with respect to people and weeks than the former two, as the row and column totals in Figs. 1  and 2 indicate.
There have been few attempts to estimate long-term variation of enzyme activities in normal humans. Glassy & Blumenfeld (1968) investigated the variation at weekly intervals of a number of plasma constituents including ALP and AST, in four groups of twelve healthy subjects. Each subject was studied at weekly intervals for 12 weeks and this study period was repeated each year at the same time for 3 years. Few results were presented, but the conclusion reached was that the range of results for an individual was narrower than the range for a group of individuals.
Mefferd & Pokorny (1967) compared the long-term variation of enzyme activities of individuals in a small group of volunteers with variation from a much larger group, analysed on a single occasion, for a number of laboratory assays which also included ALP and AST. Though no results were published for these enzymes it was claimed that for all assays the variation within the two groups was roughly the same. Thus a single observation from an individual might be found anywhere over the normal range.
Williams et al. (1970) in a series of detailed studies have investigated the long-term biological and analytical components of variation in sixty-eight normal volunteers over a 10-12 week period. Duplicate measurements of fifteen serum constituents were made at weekly intervals. Two groups of results were published. The first group, which excluded ALP, were based on the weekly analyses, and analytical variation calculated from the results of serum pools, used as controls. Values were obtained for the within-person variation for these constituents except for the AST, where it was shown that analytical variation was considerably greater on average than the variation attributable to the individual and thus no reliable estimate could be made. The second group of results were obtained from nine young male subjects studied weekly for 10 weeks. All samples were estimated at the same time, in duplicate. Since the between-batch variation was now eliminated estimations of within-person variability could be made more reliably. The results obtained showed that the within-person variation for the AST varied from about one-half to the same value as the between-person variation, but for ALP it was only about one-quarter the magnitude.
The results of the present study indicate that analytical variation contributes considerably to the within-person variance, but when this was allowed for, personal variation became small. Spikes of activity outside clinical normal ranges were not frequent, and when they occurred could generally be attributed either to values in a particular individual, invariably male, that were more-or-less consistently at the upper limit of this range, or less frequently to laboratory variation, or a combination of the two. The long-term within-person variation for the two enzymes was small, this applying particularly to the activity of ALP in male subjects and the activity of AST in female subjects. This variation only rarely coincided with enzyme activities greater than the upper limit of the relevant clinical normal range.
To define the significance of isolated abnormal values requires, at the very least, ranges defined with respect to each sex, and should include an estimate of laboratory variation.
(No attempt was made to analyse the results with respect to the age of individuals.) The results obtained, although not allowing reliable estimates of the variance components, nevertheless indicated that values abnormal by one set of criteria were not abnormal by others. For the two enzymes studied results for the females showed that values outside clinical normal ranges were rare, and thus should be regarded as a significant deviation from normal by all criteria defined. With respect to the males an abnormal result generally occurred when an individual's mean value lay at the upper limit of the clinical normal range, but to establish this in a situation where the individual has taken a potentially hepatotoxic drug would require an estimation of the enzyme activities in further samples. We acknowledge the generous financial assistance of the Boehringer Corporation, who in addition provided the reagents for the AST assays. Finally we thank all the donors in the study who co-operated in providing the blood samples.
